
Product Center
细致,就是对待工作的态度
产 品 中 心
products

C657179 MHI-148
MHI-148 , C657179
产品简介
MHI-148是一种具有癌症靶向能力和近红外(NIR)敏感性的光动力治疗(PDT)光敏剂。
| CAS号 : | 172971-76-5 |
货号 : | ||
分子式 : | C42H52BrClN2O4 | |
纯度 : | 99%+ | |
分子量 : | 764.23 | |
存储条件: | Pure form Keep in dark place,Sealed in dry,Store in freezer, under -20°C | |
In solvent -20°C:3-6个月-80°C:12个月 | ||
溶解度 : | DMSO: 20 mg/mL(26.17 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO | |
MDL号 : | N/A |
生物活性 | |
描述 | Photodynamic therapy (PDT) is a burgeoning method for cancer therapy attribute to low side effect, minimal invasiveness, and high space-time selectivity. IR-808 is a PDT photosensitizer with cancer-targeting ability and near-infrared (NIR) sensitivity. When irradiated by tissue-penetrable 808 nm light, the IR-808 greatly absorbs 808 nm photons and then emit a broadband peak which overlaps perfectly with the absorption of Nd3+ and Yb3+. The Nd3+/Yb3+ incorporated shell synergistically captures the emitted NIR photons to illuminate NaGdF4:Yb,Er zone and then radiate ultra-bright green and red emissions. The visible emissions simultaneously activate the dual-photosensitizer to produce a large amount of ROS and, importantly, low heating effects. IR-808 could be internalized selectively by malignant cells of samples, and these malignant cells could be easily distinguished from normal cells under a fluorescence microscope. The positive rates between cytological analysis and the IR-808 staining method were 86% (24/28) and 79% (22/28), respectively. An excellent concordance level (Kappa = 0.752, P < 0.001) was observed between the two methods |
实验方案 | |||
质量 体积 浓度 | 1mg | 5mg | 10mg |
1 mM | 1.31ml | 6.54ml | 13.09ml |
5 mM | 0.26ml | 1.31ml | 2.62ml |
10 mM | 0.13ml | 0.65ml | 1.31ml |